SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: johnsto1 who wrote (652)9/23/2000 11:59:53 PM
From: Tom Hua  Read Replies (3) of 810
 
j1, through your posts the past 2 days, you've demonstrated your eloquence, your considerable knowledge of ONYX-015, your intimate familiarity with the company. I tip my hat to you. Perhaps you can comment on the experts' expression of facts given below:

ONYX-015 has to be injected directly into the tumour to work, meaning it is of no apparent use against tumours that are not easy to reach, or against tiny tumours that are not yet visible.

The researchers said most of their patients eventually died of their cancer -- because other, untreated tumours in their body spread.

I anxiously await another of your intelligent and educational post.

Regards,

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News